CFDE Data Portal | Search LINC01559

	Label	Description
	LINC01559 Gene (Entity type)	ENSG00000180861 - long intergenic non-protein coding RNA 1559
	GSE216043 cisplatin 11 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE146982 metformin 4 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE108464 AZ-628 11 v 12 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE197555 trametinib A-549 NCI-H460 1 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE173116 GSE173118 ML-7 8 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE176366 vincristine 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE202434 GSE202438 talazoparib 9 v 14 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE198930 prunetin AGS 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE208350 H-7 Huh-7 JHH-7 0 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS

LINC01559

ENSG00000180861 - long intergenic non-protein coding RNA 1559

GSE216043 cisplatin 11 v 2 human dn

A Gene Set from LINCS

GSE146982 metformin 4 v 2 human up

A Gene Set from LINCS

GSE108464 AZ-628 11 v 12 human up

A Gene Set from LINCS

GSE197555 trametinib A-549 NCI-H460 1 v 2 human dn

A Gene Set from LINCS

GSE173116 GSE173118 ML-7 8 v 5 human dn

A Gene Set from LINCS

GSE176366 vincristine 3 v 2 human dn

A Gene Set from LINCS

GSE202434 GSE202438 talazoparib 9 v 14 human dn

A Gene Set from LINCS

GSE198930 prunetin AGS 1 v 0 human dn

A Gene Set from LINCS

GSE208350 H-7 Huh-7 JHH-7 0 v 3 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.